Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Stockholders Equity (unaudited)

v3.20.4
Consolidated Statements of Changes in Stockholders Equity (unaudited) - USD ($)
Total
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Income (Deficit)
Balance, shares at Jan. 31, 2019   100,000 5,460,000    
Balance, amount at Jan. 31, 2019 $ (434,593) $ 10 $ 546 $ 3,486,104 $ (3,921,253)
Conversion of preferred to common, shares   (100,000) 5,000,000    
Conversion of preferred to common, amount 0 $ (10) $ 500 (490) 0
Imputed Interest 11,427     11,427  
Net loss (144,432) $ 0 $ 0 0 (144,432)
Balance, shares at Oct. 31, 2019   10,460,000    
Balance, amount at Oct. 31, 2019 (567,598) $ 0 $ 1,046 3,497,041 (4,065,685)
Balance, shares at Jan. 31, 2020   10,460,000    
Balance, amount at Jan. 31, 2020 (607,507) $ 0 $ 1,046 3,500,892 (4,109,445)
Imputed Interest (52,705) 0 0 (52,705) 0
Net loss (49,405,874) $ 0 $ 0   (49,405,874)
Conversion of common to series B preferred, shares   500,000 (5,000,000)    
Conversion of common to series B preferred, amount 0 $ 50 $ (500) 450  
Conversion of accounts payable, shares   246,317    
Conversion of accounts payable, amount 1,662,665 $ 0 $ 25 1,662,640  
Issuance of Series A preferred, shares   150,000    
Issuance of Series A preferred, amount 40,137,788 $ 15 $ 0 40,137,773  
Issuance of series B preferred, shares   150,000    
Issuance of series B preferred, amount 6,548,188 $ 15 $ 0 6,548,173  
Interest receivable - related party 55,232     55,232  
Shares issued for service, shares     153,846    
Shares issued for service, amount 1,038,460   $ 15 1,038,445  
Sale of assets 1,900,000     1,900,000  
Warrant exercise, shares     20,000    
Warrant exercise, amount 20,000   $ 2 19,998  
Balance, shares at Oct. 31, 2020   800,000 5,880,163    
Balance, amount at Oct. 31, 2020 $ 1,296,247 $ 80 $ 588 $ 54,810,898 $ (53,515,319)